Historic Real-World Outcomes and Future Benchmarks for Patients with Diffuse Large B-Cell Lymphoma Receiving First- and Second-Line Therapy in Austria – a Large Single-Center ExperienceMichael Leisch, Thomas Melchardt, Gianfranco Pocobelli et al.|Technology in Cancer Research & Treatment|2026Cited by 0
Author response for "Historic real-world outcomes and future benchmarks for patients with diffuse large B-cell lymphoma receiving first- and second-line therapy in Austria – a large single-center experience"Michael Leisch, Thomas Melchardt, Dominik Kiem et al.|Unknown|2025Cited by 0